-
1
-
-
0032508056
-
Infection in organ transplant recipients
-
Fishman J.A., and Rubin R.H. Infection in organ transplant recipients. N Engl J Med 338 (1998) 1741
-
(1998)
N Engl J Med
, vol.338
, pp. 1741
-
-
Fishman, J.A.1
Rubin, R.H.2
-
2
-
-
16644369923
-
Cytomegalovirus
-
Green M., and Avery R. Cytomegalovirus. Am J Transplant 4 suppl 10 (2004) 51
-
(2004)
Am J Transplant
, vol.4
, Issue.SUPPL. 10
, pp. 51
-
-
Green, M.1
Avery, R.2
-
3
-
-
13144268553
-
Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report
-
Preiksaitis J.K., Brennan D.C., Fishman J., et al. Canadian Society of Transplantation consensus workshop on cytomegalovirus management in solid organ transplantation final report. Am J Transplant 5 (2005) 218
-
(2005)
Am J Transplant
, vol.5
, pp. 218
-
-
Preiksaitis, J.K.1
Brennan, D.C.2
Fishman, J.3
-
4
-
-
0001864473
-
Infections in the organ transplant recipient
-
Rubin R.H., and Young L.S. (Eds), Kluwer Academic/Plenum, New York
-
Rubin R.H. Infections in the organ transplant recipient. In: Rubin R.H., and Young L.S. (Eds). Clinical Approach to Infection in the Compromised Host. 4th Ed. (2002), Kluwer Academic/Plenum, New York 573
-
(2002)
Clinical Approach to Infection in the Compromised Host. 4th Ed.
, pp. 573
-
-
Rubin, R.H.1
-
5
-
-
0024361608
-
A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts
-
Balfour Jr. H.H., Chace B.A., Stapleton J.T., et al. A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. N Engl J Med 320 (1989) 1381
-
(1989)
N Engl J Med
, vol.320
, pp. 1381
-
-
Balfour Jr., H.H.1
Chace, B.A.2
Stapleton, J.T.3
-
6
-
-
4043109117
-
Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation
-
Ciancio G., Burke G.W., Mattiazzi A., et al. Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation. Clin Transplant 18 (2004) 402
-
(2004)
Clin Transplant
, vol.18
, pp. 402
-
-
Ciancio, G.1
Burke, G.W.2
Mattiazzi, A.3
-
7
-
-
33749163089
-
Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy
-
Baillie G.M. Prevention of cytomegalovirus disease in solid organ transplant patients: prophylactic versus preemptive therapy. Am J Health Syst Pharm 63 19 suppl 5 (2006) S10
-
(2006)
Am J Health Syst Pharm
, vol.63
, Issue.19 SUPPL. 5
-
-
Baillie, G.M.1
-
8
-
-
0029013575
-
Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients
-
Hibberd P.L., Tolkoff-Rubin N.E., Conti D., et al. Preemptive ganciclovir therapy to prevent cytomegalovirus disease in cytomegalovirus antibody-positive renal transplant recipients. Ann Intern Med 123 (1995) 18
-
(1995)
Ann Intern Med
, vol.123
, pp. 18
-
-
Hibberd, P.L.1
Tolkoff-Rubin, N.E.2
Conti, D.3
-
9
-
-
0042384865
-
Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study
-
Sagedal S., Nordal K.P., Hartman A., et al. Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study. Nephrol Dial Transplant 18 (2003) 1899
-
(2003)
Nephrol Dial Transplant
, vol.18
, pp. 1899
-
-
Sagedal, S.1
Nordal, K.P.2
Hartman, A.3
-
10
-
-
0031464801
-
Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation
-
Tanabe K., Tokumoto T., Ishikawa N., et al. Comparative study of cytomegalovirus (CMV) antigenemia assay, polymerase chain reaction, serology, and shell vial assay in the early diagnosis and monitoring of CMV infection after renal transplantation. Transplantation 64 (1997) 1721
-
(1997)
Transplantation
, vol.64
, pp. 1721
-
-
Tanabe, K.1
Tokumoto, T.2
Ishikawa, N.3
-
11
-
-
33745604257
-
CMV prophylaxis- to do or not to do that is the question
-
Tan B.H. CMV prophylaxis- to do or not to do that is the question. Nephrol Dial Transplant 21 (2006) 1757
-
(2006)
Nephrol Dial Transplant
, vol.21
, pp. 1757
-
-
Tan, B.H.1
-
12
-
-
1942469969
-
Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients
-
Paya C., Humar A., Dominguez E., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 4 (2004) 611
-
(2004)
Am J Transplant
, vol.4
, pp. 611
-
-
Paya, C.1
Humar, A.2
Dominguez, E.3
-
13
-
-
4043109117
-
Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation
-
Ciancio G., Burke G.W., Mattiazzi A., et al. Cytomegalovirus prophylaxis with valganciclovir in kidney, pancreas-kidney, and pancreas transplantation. Clin Transplant 18 (2004) 402
-
(2004)
Clin Transplant
, vol.18
, pp. 402
-
-
Ciancio, G.1
Burke, G.W.2
Mattiazzi, A.3
-
14
-
-
34547829434
-
Oral valganciclovir is not inferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients
-
Victor Study Group
-
Asberg A., Humar A., Rollag H., et al., Victor Study Group. Oral valganciclovir is not inferior to intravenous ganciclovir for the treatment of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 7 (2007) 2106
-
(2007)
Am J Transplant
, vol.7
, pp. 2106
-
-
Asberg, A.1
Humar, A.2
Rollag, H.3
|